VEGF Mimetic Peptide-Modified Bifunctional Nanosystem for Targeted Drug Delivery in Myocardial Infarction.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- VEGF Mimetic Peptide-Modified Bifunctional Nanosystem for Targeted Drug Delivery in Myocardial Infarction.
- Published In:
- ACS applied bio materials, 9(4), 1998-2009 (2026)
- Authors:
- Tuerhan, Maisituremu, Tian, Hailan, Lu, Qinyi, Chen, Yaning, Wang, Zicheng, Aihemaitijiang, Aikeda, Meng, Yan, Wang, Yuji, Zheng, Yuanyuan
- Database ID:
- RPEP-16282
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16282APA
Tuerhan, Maisituremu; Tian, Hailan; Lu, Qinyi; Chen, Yaning; Wang, Zicheng; Aihemaitijiang, Aikeda; Meng, Yan; Wang, Yuji; Zheng, Yuanyuan. (2026). VEGF Mimetic Peptide-Modified Bifunctional Nanosystem for Targeted Drug Delivery in Myocardial Infarction.. ACS applied bio materials, 9(4), 1998-2009. https://doi.org/10.1021/acsabm.5c01922
MLA
Tuerhan, Maisituremu, et al. "VEGF Mimetic Peptide-Modified Bifunctional Nanosystem for Targeted Drug Delivery in Myocardial Infarction.." ACS applied bio materials, 2026. https://doi.org/10.1021/acsabm.5c01922
RethinkPeptides
RethinkPeptides Research Database. "VEGF Mimetic Peptide-Modified Bifunctional Nanosystem for Ta..." RPEP-16282. Retrieved from https://rethinkpeptides.com/research/tuerhan-2026-vegf-mimetic-peptidemodified-bifunctional
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.